High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues
Noboru Shinkai(Nagoya City University), Yasuhito Tanaka(Kumamoto University), Takashi Kumada(Gifu Kyoritsu University), Masanori Nojima, Etsuko Iio(Nagoya City University), Takako Inoue(Kaneka (United States)), Shuko Murakami(Nagoya City University), Kayoko Matsunami(Nagoya City University), Shintaro Ogawa(Nagoya City University), Hidenori Toyoda(Ogaki Municipal Hospital)
Cited by 38
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
|Journal of Hepatology|2018|559
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
|Proceedings of the National Academy of Sciences|2019|241